[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595022":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":31,"responsibleParty":72,"collaborators":10,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":10,"eligibilityCriteria":80,"healthyVolunteers":76,"sex":81,"minAge":82,"maxAge":10,"enrollmentInfo":83,"targetDuration":10,"studyType":86,"phases":10,"briefSummary":87,"conditions":88,"keywords":10,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"National Cancer Institute, Naples","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Da Vinci SP Surgical Staging Group",null,"Patients with early-stage endometrial cancer undergoing robotic surgical staging using the Da Vinci SP system.",[13],"Procedure: Robotic surgical staging",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"PROCEDURE","Robotic surgical staging","The intervention includes hysterectomy, bilateral salpingo-oophorectomy, and sentinel lymph node mapping, with possible lymphadenectomy or omentectomy, depending on histology.",[9],[21],{"name":22,"affiliation":23,"role":24},"Vito Chiantera, MD","IRCCS I.N.T. \"G. Pascale\"","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Giuseppe Cucinella, MD","CONTACT","00000000000","giuseppe.cucinella@istitutotumori.na.it",[32,48,60],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Istituto Nazionale Tumori | \"Fondazione Pascale\"","RECRUITING","Naples","Napoli","80131","Italy","IT",{"type":41,"coordinates":42},"Point",[43,44],14.26811,40.85216,{"lat":44,"lon":43},[47],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},{"facility":49,"status":34,"city":50,"state":10,"zip":10,"country":38,"countryCode":39,"cosmosGeoPoint":51,"geoPoint":55,"contacts":56},"IEO - Istituto Europeo di Oncologia","Milan",{"type":41,"coordinates":52},[53,54],12.59836,42.78235,{"lat":54,"lon":53},[57],{"name":58,"role":28,"phone":10,"phoneExt":10,"email":59},"Vanna Zanagnolo, MD","vanna.zanagnolo@ieo.it",{"facility":61,"status":34,"city":62,"state":10,"zip":10,"country":38,"countryCode":39,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"Istituti Fisioterapici Ospitalieri - IFO","Roma",{"type":41,"coordinates":64},[65,66],11.10642,44.99364,{"lat":66,"lon":65},[69],{"name":70,"role":28,"phone":10,"phoneExt":10,"email":71},"Enrico Vizza, MD","enrico.vizza@ifo.it",{"type":73,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100595022","application-of-da-vinci-sp-for-endometrial-cancer-surgical-staging-100595022",false,"NCT07027046","Application of da Vinci SP for Endometrial Cancer Surgical Staging","Application of da Vinci SP for Endometrial Cancer Surgical Staging: a Prospective Multicenter Study","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Histologically confirmed endometrial carcinoma (including uterine carcinosarcoma)\n* Performance status (ECOG) 0 - 1\n* Patients undergoing staging surgery for endometrial cancer, including but not limited to robotic hysterectomy with bilateral salpingo-oophorectomy (ovarian preservation in selected patients is not an exclusion criterion) and possible sentinel lymph node biopsy\u002Fpelvic ± para-aortic lymphadenectomy\n* Signed informed consent to participate in the study\n\nExclusion Criteria:\n\n* Patients scheduled for an additional extra-genital surgical procedure during the staging surgery for endometrial carcinoma\n* Patients with anesthesiological contraindications to a minimally invasive approach\n* Synchronous tumor\n* Recurrence of endometrial carcinoma\n* Dementia or significantly altered mental status that may impair understanding and the ability to provide informed consent\n* Any reason that may interfere with regular follow-up, even if limited to the first 30 days post-surgery","FEMALE","18 Years",{"count":84,"type":85},564,"ESTIMATED","OBSERVATIONAL","Prospective Multicenter Observational Study The study involves the consecutive inclusion of every patient with endometrial cancer undergoing staging surgical treatment using a robotic approach with the da Vinci SP platform.",[89],"Endometrial Cancer","2025-09-18",{"date":92,"type":93},"2025-09-19","ACTUAL",{"date":95,"type":93},"2025-04-03",{"date":97,"type":85},"2029-06",{"name":5,"class":6},3]